Skip to Main Content

Paper Details

Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia.
EBioMedicine
2
2023
Author NameAffiliation
Carmen MikacenicBenaroya Research Institute at Virginia Mason
Wesley H SelfVanderbilt Institute for Clinical and Translational Research and Department of Emergency Medicine, Vanderbilt University Medical Center
  • 1 - 2

Datasets

Release 1.2